SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-15-000085
Filing Date
2015-08-05
Accepted
2015-08-04 20:37:46
Documents
12
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-6301510q.htm 10-Q 1112358
2 EXHIBIT 10.1 lgndvikingmasterlicenseagr.htm EX-10.1 122732
3 EXHIBIT 10.2 lgndvikingloanandsecuritya.htm EX-10.2 35285
4 EXHIBIT 31.1 lgnd_63015exhibit311.htm EX-31.1 16315
5 EXHIBIT 31.2 lgnd_63015exhibit312.htm EX-31.2 16221
6 EXHIBIT 32.1 lgnd_63015exhibit321.htm EX-32.1 15107
  Complete submission text file 0000886163-15-000085.txt   8221230

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT lgnd-20150630.xml EX-101.INS 1830657
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20150630.xsd EX-101.SCH 52437
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20150630_cal.xml EX-101.CAL 89445
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20150630_def.xml EX-101.DEF 293072
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20150630_lab.xml EX-101.LAB 879963
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20150630_pre.xml EX-101.PRE 474056
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 151027190
SIC: 2834 Pharmaceutical Preparations